LIGHT, a member of the TNF superfamily, activates Stat3 mediated by NIK pathway

Nagalakshmi Nadiminty1, Jae Yeon Chun, Yan Hu

  • 1Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Insights

Tumor necrosis factor superfamily member LIGHT activates signal transducers and activators of transcription 3 (Stat3) in cancer cells. This LIGHT-induced Stat3 activation promotes cancer cell growth and may enhance tumor proliferation and survival.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • Signal transducers and activators of transcription 3 (Stat3) is crucial for cell proliferation, differentiation, survival, and inflammation.
  • Constitutive Stat3 activation is common in human tumors, driving cellular transformation and tumor formation.

Purpose of the Study:

  • To investigate the role of LIGHT, a tumor necrosis factor superfamily member, in Stat3 activation within cancer cells.
  • To elucidate the signaling pathway mediating LIGHT-induced Stat3 activation.

Main Methods:

  • Cancer cell treatment with LIGHT and analysis of Stat3 phosphorylation at Tyr705 and Ser727.
  • Utilizing kinase-inactive NIK mutants and active NIK overexpression to assess NIK's role in Stat3 activation.
  • Assessing Stat3 target gene expression (cyclin D1, survivin, Bcl-xL) and LNCaP prostate cancer cell growth.
  • Employing dominant-negative Stat3 mutants to block LIGHT-induced effects.

Main Results:

  • LIGHT induces dose-dependent Stat3 activation via phosphorylation at Tyr705 and Ser727.
  • LIGHT-induced Stat3 activation is mediated by NIK phosphorylation, requiring NIK's kinase activity.
  • LIGHT upregulates Stat3 target genes and stimulates prostate cancer cell proliferation, effects blocked by dominant-negative Stat3.

Conclusions:

  • LIGHT activates Stat3 in cancer cells, in addition to its known activation of NF-kappaB/p52.
  • LIGHT-mediated Stat3 activation, alongside non-canonical NF-kappaB/p52 signaling, likely amplifies cellular proliferation, survival, and inflammation in cancer.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...